HRT FINANCIAL LP
10% owner
SaleAlert
- Shares
- 34,938
- Price
- $1.40
- Value
- $48,913
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•16 filings
BJDX
Bluejay Diagnostics, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 1 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$221,711
6 distinct insiders
12-month sales
$48,913
1 distinct insiders
Highlighted alerts
7
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
1 executive purchases found
Get BJDX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
BJDX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
12
Raw transactions
Everything returned by the filing
7
Voluntary view
P/S trades after deterministic checks
5
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 100,000
- Price
- $0.00
- Footnotes
- 1
Represents out-of-the-money stock options that vest and become exercisable for $2.075 per share on the first anniversary of the grant date, provided, however, that the options shall not be exercisable unless and until the U.S. Food and Drug Administration shall have granted clearance or approval of the issuer's Symphony IL-6 point-of-care testing device.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
HRT FINANCIAL LP
10% owner
PurchaseAlert
- Shares
- 64,047
- Price
- $1.51
- Value
- $96,711
Wurth Douglas Clark
Director
PurchaseAlert
- Shares
- 12,500
- Price
- $2.00
- Value
- $25,000
Dey Indranil
President and CEO
PurchaseAlert
- Shares
- 12,500
- Price
- $2.00
- Value
- $25,000
CHASE DONALD R
Director
PurchaseAlert
- Shares
- 12,500
- Price
- $2.00
- Value
- $25,000
ZEIDMAN FRED S
Director
PurchaseAlert
- Shares
- 12,500
- Price
- $2.00
- Value
- $25,000
Dey Svetlana
Director
PurchaseAlert
- Shares
- 12,500
- Price
- $2.00
- Value
- $25,000
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | HRT FINANCIAL LP 10% owner | Sale | 34,938 | $1.40 | $48,913 | |
| Jul 09, 2026 | HRT FINANCIAL LP 10% owner | Purchase | 64,047 | $1.51 | $96,711 | |
| Mar 14, 2026 | Wurth Douglas Clark Director | Purchase | 12,500 | $2.00 | $25,000 | |
| Mar 14, 2026 | Dey Indranil President and CEO | Purchase | 12,500 | $2.00 | $25,000 | |
| Mar 14, 2026 | CHASE DONALD R Director | Purchase | 12,500 | $2.00 | $25,000 | |
| Mar 14, 2026 | ZEIDMAN FRED S Director | Purchase | 12,500 | $2.00 | $25,000 | |
| Mar 14, 2026 | Dey Svetlana Director | Purchase | 12,500 | $2.00 | $25,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.